Bank of New York Mellon’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-5,965,338
| Closed | -$592M | – | 4325 |
|
|
2019
Q3 | $592M | Sell |
5,965,338
-14,291
| -0.2% | -$1.36M | 0.16% | 119 |
|
|
2019
Q2 | $553M | Sell |
5,979,629
-109,540
| -2% | -$10.4M | 0.15% | 127 |
|
|
2019
Q1 | $574M | Sell |
6,089,169
-339,140
| -5% | -$29.7M | 0.16% | 122 |
|
|
2018
Q4 | $412M | Buy |
6,428,309
+161,938
| +3% | +$12M | 0.13% | 148 |
|
|
2018
Q3 | $561M | Sell |
6,266,371
-267,544
| -4% | -$23.6M | 0.14% | 130 |
|
|
2018
Q2 | $519M | Sell |
6,533,915
-487,641
| -7% | -$40.5M | 0.14% | 140 |
|
|
2018
Q1 | $626M | Sell |
7,021,556
-1,771,433
| -20% | -$170M | 0.17% | 113 |
|
|
2017
Q4 | $918M | Sell |
8,792,989
-715,787
| -8% | -$80.8M | 0.24% | 78 |
|
|
2017
Q3 | $1.39B | Sell |
9,508,776
-142,020
| -1% | -$19.3M | 0.38% | 53 |
|
|
2017
Q2 | $1.25B | Sell |
9,650,796
-437,677
| -4% | -$53.6M | 0.35% | 58 |
|
|
2017
Q1 | $1.26B | Buy |
10,088,473
+472,067
| +5% | +$56.5M | 0.35% | 57 |
|
|
2016
Q4 | $1.11B | Buy |
9,616,406
+155,475
| +2% | +$17.3M | 0.32% | 65 |
|
|
2016
Q3 | $989M | Buy |
9,460,931
+1,567,515
| +20% | +$170M | 0.29% | 71 |
|
|
2016
Q2 | $779M | Sell |
7,893,416
-88,556
| -1% | -$9.16M | 0.24% | 86 |
|
|
2016
Q1 | $799M | Sell |
7,981,972
-841,275
| -10% | -$86.6M | 0.24% | 85 |
|
|
2015
Q4 | $1.06B | Sell |
8,823,247
-439,768
| -5% | -$50.9M | 0.32% | 68 |
|
|
2015
Q3 | $1B | Sell |
9,263,015
-602,643
| -6% | -$74.8M | 0.31% | 66 |
|
|
2015
Q2 | $1.14B | Sell |
9,865,658
-1,539,630
| -13% | -$176M | 0.31% | 66 |
|
|
2015
Q1 | $1.32B | Sell |
11,405,288
-482,839
| -4% | -$57.7M | 0.34% | 63 |
|
|
2014
Q4 | $1.33B | Buy |
11,888,127
+862,028
| +8% | +$90.9M | 0.35% | 59 |
|
|
2014
Q3 | $1.05B | Buy |
11,026,099
+616,711
| +6% | +$55.7M | 0.28% | 73 |
|
|
2014
Q2 | $894M | Sell |
10,409,388
-163,804
| -2% | -$12.5M | 0.24% | 85 |
|
|
2014
Q1 | $738M | Sell |
10,573,192
-1,428,308
| -12% | -$113M | 0.2% | 98 |
|
|
2013
Q4 | $1.01B | Sell |
12,001,500
-369,422
| -3% | -$29.2M | 0.28% | 72 |
|
|
2013
Q3 | $953M | Buy |
12,370,922
+409,918
| +3% | +$28.7M | 0.28% | 71 |
|
|
2013
Q2 | $700M | Buy |
+11,961,004
| New | +$720M | 0.22% | 91 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Bank of New York Mellon's CELG Position: Q4 2019 in Review
Bank of New York Mellon sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,965,338 shares — an estimated $592M sold.
Bank of New York Mellon first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.39B in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Bank of New York Mellon reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Bank of New York Mellon sold 5,965,338 Celgene Corp shares in Q4 2019, an estimated $592M.
- Bank of New York Mellon first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Bank of New York Mellon's Celgene Corp position peaked at $1.39B in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Bank of New York Mellon's 13F filing for Q4 2019, filed 14 Feb 2020.